# LexinFintech Holdings Ltd.: Form 20-F for the period ended Dec 31, 2024

- Company: [LexinFintech Holdings Ltd.](/companies/lx.md) (CIK 1708259)
- Form: 20-F
- Filed: 2025-04-18
- Accepted by EDGAR: Apr 18, 2025, 11:07 ET
- Period: 2024-12-31
- Accession: 0000950170-25-055749
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1708259/000095017025055749/lx-20241231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1708259/000095017025055749/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | $1.95bn | us-gaap:Revenues |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-31 | $1.26bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2024-01-01 to 2024-12-31 | $688.6m | us-gaap:GrossProfit |
| Research and development | 12 months, 2024-01-01 to 2024-12-31 | $79.2m | us-gaap:ResearchAndDevelopmentExpense |
| Interest expense | 12 months, 2024-01-01 to 2024-12-31 | $1.2m | us-gaap:InterestExpense |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | $34.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | $150.8m | us-gaap:ProfitLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | CNY 3.24 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 12 months, 2024-01-01 to 2024-12-31 | 339,261,349 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | $148.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | $33.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2024-01-01 to 2024-12-31 | $22.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2024-12-31 | $308.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $2.45bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $3.05bn | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $1.32bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $1.58bn | us-gaap:Liabilities |
| Long-term debt | at 2024-12-31 | $80.1m | us-gaap:LongTermDebt |
| Short-term borrowings | at 2024-12-31 | CNY 49.8m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2024-12-31 | $1.47bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1708259/000095017025055749/lx-20241231.htm

Filed Apr 18, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-055749. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.